REQUEST A DEMO
Total
USD $0.00
Search more companies

Viatris Healthcare D.O.O. (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Viatris Healthcare D.O.O. Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Viatris Healthcare d.o.o. is the Serbian affiliate of Viatris, a global biopharmaceutical company formed from the merger of Mylan and Upjohn. The company markets and distributes prescription medicines, generics, over the counter products and specialized therapies across therapeutic areas including cardiology, endocrinology, pulmonology, neurology and infectious diseases. It cooperates with healthcare institutions, pharmacies and distributors throughout Serbia. Key assets include a broad pharmaceutical portfolio, established regulatory and medical support capabilities and access to Viatris global resources. Strategically, Viatris Healthcare aims to expand patient access to high quality, affordable medicines and support public health needs through a diversified therapy portfolio.

Headquarters
Bulevar Mihajla Pupina 115A
Belgrade; Belgrade;

Contact Details: Purchase the Viatris Healthcare D.O.O. report to view the information.

Website: https://www.viatris.com/

Basic Information
Total Employees:
Purchase the Viatris Healthcare D.O.O. report to view the information.
Registered Capital:
Purchase the Viatris Healthcare D.O.O. report to view the information.
Financial Auditors:
Purchase the Viatris Healthcare D.O.O. report to view the information.
Incorporation Date:
January 16, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Viatris Healthcare D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
13.84%
Total operating revenue
13.51%
Operating profit (EBIT)
42.84%
EBITDA
33.81%
Net Profit (Loss) for the Period
47.57%
Total Assets
22.99%
Total Equity
42.85%
Operating Profit Margin (ROS)
0.87%
Net Profit Margin
0.8%
Return on Equity (ROE)
0.96%
Debt/Equity
-109.41%
Quick Ratio
-0.34%
Cash Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?